Catalyst Wire Dossier Catalyst Wire Dossier

Insulin Icodec

insulin icodec · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Insulin Icodec, covering 2024-07-12 to 2026-07-02. Get the full timeline:

Most recent: Clinical Trial Results: A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes [Phase 3]

See pricing